123 related articles for article (PubMed ID: 16354354)
21. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
Li Y; Xu Z; Zhang L; Quan C; Lin X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
[TBL] [Abstract][Full Text] [Related]
22. Expression of oestrogen-related receptor alpha in human epidermis.
Bertil E; Bolzinger MA; André V; Rousselle P; Damour O
Exp Dermatol; 2008 Mar; 17(3):208-13. PubMed ID: 18070081
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of placenta growth factor in human middle ear cholesteatoma.
Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
[TBL] [Abstract][Full Text] [Related]
24. Expression of estrogen-related receptor gamma (ERRgamma) in human skin.
Krahn-Bertil E; Bolzinger MA; Andre V; Orly I; Kanitakis J; Rousselle P; Damour O
Eur J Dermatol; 2008; 18(4):427-32. PubMed ID: 18573717
[TBL] [Abstract][Full Text] [Related]
25. Galanin receptor expression in cultured human keratinocytes and in normal human skin.
Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
J Peripher Nerv Syst; 2006 Jun; 11(2):156-64. PubMed ID: 16787514
[TBL] [Abstract][Full Text] [Related]
26. Detection of West Nile virus in formalin-fixed, paraffin-embedded human tissues by RT-PCR: a useful adjunct to conventional tissue-based diagnostic methods.
Bhatnagar J; Guarner J; Paddock CD; Shieh WJ; Lanciotti RS; Marfin AA; Campbell GL; Zaki SR
J Clin Virol; 2007 Feb; 38(2):106-11. PubMed ID: 17161650
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of human beta defensin 2 and human beta defensin 3 in human middle ear cholesteatoma.
Song JJ; Chae SW; Woo JS; Lee HM; Jung HH; Hwang SJ
Ann Otol Rhinol Laryngol; 2007 Mar; 116(3):235-40. PubMed ID: 17419529
[TBL] [Abstract][Full Text] [Related]
30. Expression of tumor necrosis factor-like weak inducer of apoptosis in human middle ear cholesteatoma.
Park M; Lee B; Lee J
ORL J Otorhinolaryngol Relat Spec; 2013; 75(4):221-7. PubMed ID: 23900149
[TBL] [Abstract][Full Text] [Related]
31. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
[TBL] [Abstract][Full Text] [Related]
33. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of Ki-67, oestrogen and progesterone receptors in acoustic neuroma.
Cafer S; Bayramoglu I; Uzum N; Yilmaz M; Memis L; Uygur K
J Laryngol Otol; 2008 Feb; 122(2):125-7. PubMed ID: 17666143
[TBL] [Abstract][Full Text] [Related]
35. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
36. Cyclo-oxygenase-2 (COX-2) mRNA expression and hormone receptor status in breast cancer.
McCarthy K; Bustin SA; Ogunkolade B; Khalaf S; Laban CA; McVittie CJ; Carpenter R; Jenkins PJ
Eur J Surg Oncol; 2006 Sep; 32(7):707-9. PubMed ID: 16650963
[TBL] [Abstract][Full Text] [Related]
37. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
[TBL] [Abstract][Full Text] [Related]
38. The role of S100A1 in external auditory canal cholesteatoma.
Naim R; Hormann K
Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
[TBL] [Abstract][Full Text] [Related]
39. Analysis of gene expression profiles in cholesteatoma using oligonucleotide microarray.
Kwon KH; Kim SJ; Kim HJ; Jung HH
Acta Otolaryngol; 2006 Jul; 126(7):691-7. PubMed ID: 16803706
[TBL] [Abstract][Full Text] [Related]
40. Expression of progesterone receptor in human keratinocytes.
Im S; Lee ES; Kim W; Song J; Kim J; Lee M; Kang WH
J Korean Med Sci; 2000 Dec; 15(6):647-54. PubMed ID: 11194191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
